Celularity’s Massively Transformative Purpose (MTP) is to harness the power of the living cell to augment biology, immunity and longevity.
Celularity is a biotechnology company productizing allogeneic cells and tissues derived from the postpartum placenta. These materials have the ability to augment our immunity and longevity by amplifying the body’s ability to fight disease, heal, and regenerate itself.
Peter's Role: Co-Founder and Vice Chairman
Peter H. Diamandis, MD Co-Founder and Vice Chairman (left)
Bob Hariri, MD, PhD Founder, Chairman & CEO (right)